Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Consolidated Statements of Operations
Grant revenue	$ 5,174	$ 4,529
Operating expenses
Research and development	34,426	33,770
General and administrative	13,184	11,649
Total operating expenses	47,610	45,419
Operating loss	(42,436)	(40,890)
Other income (expense)
Interest income	697	179
Interest expense	(10,742)	(2,626)
Change in fair value of the Convertible Loan	31,399	(21,845)
Gain (loss) on debt and the Convertible Loan extinguishments	2,166	(3,863)
Total other income (expense), net	23,520	(28,155)
Net loss	$ (18,916)	$ (69,045)
Per share information:
Net loss per share, basic	$ (0.52)	$ (1.91)
Weighted average shares outstanding, basic	36,160,848	36,075,555
Net loss per share, diluted	$ (0.89)	$ (1.91)
Weighted average shares outstanding, diluted	59,059,971	36,075,555